▶ 調査レポート

麻酔装置および呼吸器の世界市場:麻酔装置別(麻酔モニター、麻酔気化装置、鎮痛装置、麻酔マスク、麻酔装置付属品)、呼吸器別(加湿器、蘇生器、呼吸回路、チャンバー、CPAP装置、マスク、酸素濃縮器、ネブライザー、人工呼吸器、吸入器、気管切開チューブ、酸素カニューレ、カプノグラフ、肺活量計)、地域別分析

• 英文タイトル:Global Anesthesia & Respiratory Devices Market - Segmented by Product Type, Application, Marker Type and Geography - Growth, Trends and Forecasts (2018 - 2023)

Mordor Intelligenceが調査・発行した産業分析レポートです。麻酔装置および呼吸器の世界市場:麻酔装置別(麻酔モニター、麻酔気化装置、鎮痛装置、麻酔マスク、麻酔装置付属品)、呼吸器別(加湿器、蘇生器、呼吸回路、チャンバー、CPAP装置、マスク、酸素濃縮器、ネブライザー、人工呼吸器、吸入器、気管切開チューブ、酸素カニューレ、カプノグラフ、肺活量計)、地域別分析 / Global Anesthesia & Respiratory Devices Market - Segmented by Product Type, Application, Marker Type and Geography - Growth, Trends and Forecasts (2018 - 2023) / B-MOR-040835資料のイメージです。• レポートコード:B-MOR-040835
• 出版社/出版日:Mordor Intelligence / 2018年2月
• レポート形態:英文、PDF、118ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:医療・バイオ
• 販売価格(消費税別)
  Single User(1名様用)¥573,750 (USD4,250)▷ お問い合わせ
  Team User(7名様用)¥607,500 (USD4,500)▷ お問い合わせ
  Corporate User¥1,181,250 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、麻酔装置および呼吸器の世界市場について調べ、麻酔装置および呼吸器の世界規模、市場動向、市場環境、麻酔装置別(麻酔モニター、麻酔気化装置、鎮痛装置、麻酔マスク、麻酔装置付属品)分析、呼吸器別(加湿器、蘇生器、呼吸回路、チャンバー、CPAP装置、マスク、酸素濃縮器、ネブライザー、人工呼吸器、吸入器、気管切開チューブ、酸素カニューレ、カプノグラフ、肺活量計)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・麻酔装置および呼吸器の世界市場インサイト
・麻酔装置および呼吸器の世界市場環境
・麻酔装置および呼吸器の世界市場動向
・麻酔装置および呼吸器の世界市場規模
・麻酔装置および呼吸器の世界市場規模:麻酔装置別(麻酔モニター、麻酔気化装置、鎮痛装置、麻酔マスク、麻酔装置付属品)
・麻酔装置および呼吸器の世界市場規模:呼吸器別(加湿器、蘇生器、呼吸回路、チャンバー、CPAP装置、マスク、酸素濃縮器、ネブライザー、人工呼吸器、吸入器、気管切開チューブ、酸素カニューレ、カプノグラフ、肺活量計)
・麻酔装置および呼吸器の世界市場:地域別市場規模・分析
・麻酔装置および呼吸器の北米市場規模・予測
・麻酔装置および呼吸器のアメリカ市場規模・予測
・麻酔装置および呼吸器のヨーロッパ市場規模・予測
・麻酔装置および呼吸器のアジア市場規模・予測
・麻酔装置および呼吸器の日本市場規模・予測
・麻酔装置および呼吸器の中国市場規模・予測
・麻酔装置および呼吸器のインド市場規模・予測
・麻酔装置および呼吸器の韓国市場規模・予測
・関連企業情報・競争状況

As of 2017, the market for anesthetic & respiratory devices reached a value of USD 20.5 billion. This market is expected to reach USD 36.9 billion by 2023, at a CAGR of about 10.29% during 2018-2023 (the forecast period).

Increasing Number of Surgeries

The demand for various anesthetic drugs is directly related to the number of surgeries performed. Anesthesia is a necessity in almost every type of surgery, as it helps in reducing the pain during the procedure. On the global level, over 230 million surgeries are performed every year. In the coming years, with the growing population, longer life expectancy, increasing diseases resulting in surgical requirements, and rising number of injuries, the demand for anesthetic drugs is expected to increase. Also, this demand is being affected by the growing safety awareness and the technology enhancements in anesthesia machines. Low-flow anesthesia and electronic medical records dominate the current anesthesia market, which is affecting the savings across the healthcare industry. The growing patient populations, suffering from sleep disorders, such as Obstructive Sleep Apnea (OSA), and respiratory diseases, such as Chronic Obstructive Pulmonary Diseases (COPD), has been the major growth driver for this market.

Side Effects of General Anesthetics

Many general anesthetic drugs can cause physiological changes, like blood pressure variations, and due to this, a trained anesthesiologist should continuously monitor the patient’s blood pressure levels. Regional anesthesia have potential side effects, which include back pain, difficulty in urinating, hematoma, and severe complications, such as pneumothorax and nerve damage. Local anesthesia numbs the targeted body part; hence, the adverse aftereffects are minimum and depend on the amount of the drug administered. Moreover, the side effects of general anesthesia and the patient’s reluctance toward using it are restraining the growth of this segment.
The decrease in the reimbursements provided by governments for medical equipment and increased availability of aftermarket service that prolongs the life of a facility’s existing equipment are the challenges restraining the market growth.

North America Holds the Major Market

North America occupies a major share of 32% of the market. This fact can be attributed to the high per capita income of the North American population and the rapidly rising patient population. Following North America is Europe with the second-largest market share of about 29%. Recent trends show that emerging countries are likely to witness an increase in their growth rates, due to the increasing per capita income and the rapidly growing patient population.

Key Developments in the Market

• January 2018: BOMImed partnered with Mindray North America.
• April 2017: BD acquired Caesarea Medical Electronics.

Major Players: 3M, AIRSEP CORP, ALUNG TECHNOLOGIES INC., ASTRAZENECA, BOMIMED INC., CAREFUSION INC., COVIDIEN PLC, DRAGERWERK AG, FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED, GE HEALTHCARE, amongst others.

Reasons to Purchase this Report

• Current and future anesthetic and respiratory devices market outlook in the developed and emerging markets
• Analyzing various perspectives of the market, with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies that are employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in excel)

Customization of the Report

• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.

レポート目次

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Surgical Procedures Requiring Anesthesia
6.1.2 Technological Advancements
6.1.3 Increasing Patient Population
6.2 Market Restraints
6.2.1 Expensive Devices
6.2.2 Decrease in the Reimbursements Provided by Government
6.2.3 Increased Sophistication and Technologies of the Machines
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Anesthesia Devices
7.1.1 Anesthesia Machines
7.1.2 Anesthetic Monitors
7.1.3 Anesthetic Vaporizers
7.1.4 Analgesic Machines
7.1.5 Anesthetic Masks
7.1.6 Anesthetic Accessories
7.2 By Respiratory Devices
7.2.1 Humidifiers
7.2.2 Resuscitators
7.2.3 Breathing Circuits
7.2.4 Chambers
7.2.5 CPAP Devices
7.2.6 Masks
7.2.7 Oxygen Concentrators
7.2.8 Nebulizers
7.2.9 Ventilators
7.2.10 Inhalers
7.2.11 Tracheostomy Tubes
7.2.12 Oxygen Cannulas
7.2.13 Capnographs
7.2.14 Spirometers
7.3 By Geography
7.3.1 North America
7.3.1.1US
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 France
7.3.2.2 Germany
7.3.2.3 UK
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest of Europe (RoE)
7.3.3 Asia-Pacific
7.3.3.1 China
7.3.3.2 Japan
7.3.3.3 India
7.3.3.4 Australia
7.3.3.5 South Korea
7.3.3.6 Rest of Asia-Pacific
7.3.4 Middle East and Africa
7.3.4.1 GCC
7.3.4.2 South Africa
7.3.4.3 Rest of Middle East and Africa
7.3.4.4 South America
7.3.4.5 Brazil
7.3.4.6 Argentina
7.3.4.7 Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations & Partnerships
8.3 New Products Launches
9. Key Players
9.1 3M
9.2 Airsep Corp
9.3 Alung Technologies Inc.
9.4 Astrazeneca
9.5 Bomimed Inc.
9.6 Carefusion Inc.
9.7 Covidien Plc
9.8 Dragerwerk Ag
9.9 Fisher & Paykel Healthcare Corporation Limited
9.10 GE Healthcare
10. Future of the Market